Patents by Inventor Thomas C. Schulz

Thomas C. Schulz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11920154
    Abstract: The present invention provides compositions and methods for the culture and maintenance of pluripotent stem cells. More particularly, the present invention provides for compositions and methods for culturing, maintaining, growing and stabilizing primate pluripotent stem cells in a feeder-free defined media further comprising human serum, or a soluble attachment component of the human serum, for promoting cell attachment.
    Type: Grant
    Filed: October 19, 2020
    Date of Patent: March 5, 2024
    Assignee: ViaCyte, Inc.
    Inventors: Allan J Robins, Thomas C Schulz
  • Publication number: 20210324329
    Abstract: The present invention relates to methods for production of undifferentiated or differentiated embryonic stem cell aggregate suspension cultures from undifferentiated or differentiated embryonic stem cell single cell suspensions and methods of differentiation thereof.
    Type: Application
    Filed: May 24, 2021
    Publication date: October 21, 2021
    Inventor: Thomas C. Schulz
  • Patent number: 11015170
    Abstract: The present invention relates to methods for production of undifferentiated or differentiated embryonic stem cell aggregate suspension cultures from undifferentiated or differentiated embryonic stem cell single cell suspensions and methods of differentiation thereof.
    Type: Grant
    Filed: November 26, 2018
    Date of Patent: May 25, 2021
    Assignee: VIACYTE, INC.
    Inventor: Thomas C Schulz
  • Publication number: 20210047616
    Abstract: The present invention provides compositions and methods for the culture and maintenance of pluripotent stem cells. More particularly, the present invention provides for compositions and methods for culturing, maintaining, growing and stabilizing primate pluripotent stem cells in a feeder-free defined media further comprising human serum, or a soluble attachment component of the human serum, for promoting cell attachment.
    Type: Application
    Filed: October 19, 2020
    Publication date: February 18, 2021
    Inventors: Allan J Robins, Thomas C Schulz
  • Patent number: 10808223
    Abstract: The present invention provides compositions and methods for the culture and maintenance of pluripotent stem cells. More particularly, the present invention provides for compositions and methods for culturing, maintaining, growing and stabilizing primate pluripotent stem cells in a feeder-free defined media further comprising human serum, or a soluble attachment component of the human serum, for promoting cell attachment.
    Type: Grant
    Filed: April 1, 2019
    Date of Patent: October 20, 2020
    Assignee: VIACYTE, INC.
    Inventors: Allan J Robins, Thomas C Schulz
  • Publication number: 20190225938
    Abstract: The present invention provides compositions and methods for the culture and maintenance of pluripotent stem cells. More particularly, the present invention provides for compositions and methods for culturing, maintaining, growing and stabilizing primate pluripotent stem cells in a feeder-free defined media further comprising human serum, or a soluble attachment component of the human serum, for promoting cell attachment.
    Type: Application
    Filed: April 1, 2019
    Publication date: July 25, 2019
    Inventors: Allan J Robins, Thomas C Schulz
  • Patent number: 10246680
    Abstract: The present invention provides compositions and methods for the culture and maintenance of pluripotent stem cells. More particularly, the present invention provides for compositions and methods for culturing, maintaining, growing and stabilizing primate pluripotent stem cells in a feeder-free defined media further comprising human serum, or a soluble attachment component of the human serum, for promoting cell attachment.
    Type: Grant
    Filed: February 22, 2016
    Date of Patent: April 2, 2019
    Assignee: VIACYTE, INC.
    Inventors: Allan J Robins, Thomas C Schulz
  • Publication number: 20190093076
    Abstract: The present invention relates to methods for production of undifferentiated or differentiated embryonic stem cell aggregate suspension cultures from undifferentiated or differentiated embryonic stem cell single cell suspensions and methods of differentiation thereof.
    Type: Application
    Filed: November 26, 2018
    Publication date: March 28, 2019
    Inventor: Thomas C. Schulz
  • Patent number: 10138463
    Abstract: The present invention relates to methods for production of undifferentiated or differentiated embryonic stem cell aggregate suspension cultures from undifferentiated or differentiated embryonic stem cell single cell suspensions and methods of differentiation thereof.
    Type: Grant
    Filed: November 24, 2014
    Date of Patent: November 27, 2018
    Assignee: VIACYTE, INC.
    Inventor: Thomas C Schulz
  • Patent number: 9458426
    Abstract: The present invention relates to compositions and methods for maintaining undifferentiated pluripotent stem cell cultures.
    Type: Grant
    Filed: January 22, 2014
    Date of Patent: October 4, 2016
    Assignee: VIACYTE, INC.
    Inventors: Thomas C Schulz, Allan J Robins
  • Publication number: 20160222346
    Abstract: The present invention provides compositions and methods for the culture and maintenance of pluripotent stem cells. More particularly, the present invention provides for compositions and methods for culturing, maintaining, growing and stabilizing primate pluripotent stem cells in a feeder-free defined media further comprising human serum, or a soluble attachment component of the human serum, for promoting cell attachment.
    Type: Application
    Filed: February 22, 2016
    Publication date: August 4, 2016
    Inventors: Allan J. Robins, Thomas C. Schulz
  • Publication number: 20160145569
    Abstract: The present invention relates to cell culture methods and compositions that are essentially serum-free and comprise a basal salt nutrient solution and an ErbB3 ligand.
    Type: Application
    Filed: September 23, 2015
    Publication date: May 26, 2016
    Inventors: Allan J. Robins, Thomas C. Schulz
  • Patent number: 9267110
    Abstract: The present invention provides compositions and methods for the culture and maintenance of pluripotent stem cells. More particularly, the present invention provides for compositions and methods for culturing, maintaining, growing and stabilizing primate pluripotent stem cells in a feeder-free defined media further comprising human serum, or a soluble attachment component of the human serum, for promoting cell attachment.
    Type: Grant
    Filed: December 10, 2013
    Date of Patent: February 23, 2016
    Assignee: VIACYTE, INC.
    Inventors: Allan J Robins, Thomas C Schulz
  • Publication number: 20150132846
    Abstract: The present invention relates to methods for production of undifferentiated or differentiated embryonic stem cell aggregate suspension cultures from undifferentiated or differentiated embryonic stem cell single cell suspensions and methods of differentiation thereof.
    Type: Application
    Filed: November 24, 2014
    Publication date: May 14, 2015
    Inventor: Thomas C. Schulz
  • Patent number: 8895300
    Abstract: The present invention relates to methods for production of undifferentiated or differentiated embryonic stem cell aggregate suspension cultures from undifferentiated or differentiated embryonic stem cell single cell suspensions and methods of differentiation thereof.
    Type: Grant
    Filed: November 8, 2012
    Date of Patent: November 25, 2014
    Assignee: Viacyte, Inc.
    Inventor: Thomas C Schulz
  • Publication number: 20140186948
    Abstract: The present invention relates to compositions and methods for maintaining undifferentiated pluripotent stem cell cultures.
    Type: Application
    Filed: January 22, 2014
    Publication date: July 3, 2014
    Applicant: ViaCyte, Inc.
    Inventors: Thomas C Schulz, Allan J Robins
  • Publication number: 20140154802
    Abstract: The present invention relates to cell culture methods and compositions that are essentially serum-free and comprise a basal salt nutrient solution and an ErbB3 ligand.
    Type: Application
    Filed: February 10, 2014
    Publication date: June 5, 2014
    Applicant: Viacyte, Inc.
    Inventors: Allan J. Robins, Thomas C. Schulz
  • Publication number: 20140099713
    Abstract: The present invention provides compositions and methods for the culture and maintenance of pluripotent stem cells. More particularly, the present invention provides for compositions and methods for culturing, maintaining, growing and stabilizing primate pluripotent stem cells in a feeder-free defined media further comprising human serum, or a soluble attachment component of the human serum, for promoting cell attachment.
    Type: Application
    Filed: December 10, 2013
    Publication date: April 10, 2014
    Applicant: ViaCyte, Inc.
    Inventors: Allan J. Robins, Thomas C. Schulz
  • Patent number: 8685726
    Abstract: The present invention relates to compositions and methods for maintaining undifferentiated pluripotent stem cell cultures.
    Type: Grant
    Filed: April 27, 2010
    Date of Patent: April 1, 2014
    Assignee: Viacyte, Inc.
    Inventors: Thomas C Schulz, Allan J Robins
  • Patent number: 8658352
    Abstract: The present invention relates to cell culture methods and compositions that are essentially serum-free and comprise a basal salt nutrient solution and an ErbB3 ligand.
    Type: Grant
    Filed: March 12, 2013
    Date of Patent: February 25, 2014
    Assignee: ViaCyte, Inc.
    Inventors: Allan J. Robins, Thomas C. Schulz